JFL Life Sciences Ltd

JFL Life Sciences Ltd witnessed a significant surge in trading activity on 18 Dec 2025, hitting its upper circuit price limit of ₹12.75. The stock recorded a maximum daily gain of 4.94%, outperforming its sector and broader market indices, driven by robust buying interest and a notable rise in delivery volumes.

Shares of JFL Life Sciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, plunged to their new 52-week and all-time low of ₹11.25 on 10 Dec 2025, hitting the lower circuit limit amid intense selling pressure and subdued investor participation.

JFL Life, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently undergone a revision in its evaluation metrics, reflecting nuanced shifts across key analytical parameters. This update comes amid a challenging market environment where the stock has experienced significant volatility and a prolonged downward trend over the past year.

JFL Life Sciences Ltd witnessed a significant surge in its share price on 5 Dec 2025, hitting the upper circuit limit of 5%, closing at ₹11.95. This movement was driven by robust buying interest, resulting in a maximum daily gain of 4.82%, outperforming its sector and broader market indices.

JFL Life Sciences Ltd witnessed extraordinary buying momentum on 5 Dec 2025, hitting the upper circuit with only buy orders in the queue and no sellers present. This rare market phenomenon signals intense demand and the possibility of a multi-day circuit scenario, drawing significant attention from investors and market watchers alike.

JFL Life Sciences Ltd has encountered significant selling pressure, with the stock registering a sharp decline and exhibiting a complete absence of buyers on the trading day. The pharmaceutical and biotechnology company’s shares have been under sustained downward momentum, reflecting distress selling signals and a challenging market environment.

Shares of JFL Life Sciences Ltd plunged to their lower circuit limit on 21 Nov 2025, reflecting intense selling pressure and a sharp decline of 5.04% in a single trading session. The stock closed at ₹12.25, matching its intraday low and moving closer to its 52-week low, signalling heightened investor caution in the Pharmaceuticals & Biotechnology sector.

JFL Life Sciences Ltd is experiencing severe selling pressure, with the stock hitting a lower circuit and an absence of buyers on the trading floor. The pharmaceutical and biotechnology company’s shares have recorded consecutive losses across multiple time frames, signalling distress selling and a challenging market environment.

JFL Life Sciences Ltd faced notable trading activity as its stock hit the lower circuit limit, closing at Rs 12.75. The total traded volume was 0.06 lakh shares, with a significant decline in investor participation. The stock is currently underperforming compared to its sector and trading below key moving averages.

JFL Life Sciences Ltd, a microcap in the Pharmaceuticals & Biotechnology sector, experienced notable trading activity today, hitting the upper circuit limit. The stock demonstrated strong performance with increased investor participation, as indicated by a significant rise in delivery volume. It maintains a market capitalization of Rs 46.00 crore.

JFL Life Sciences Ltd is experiencing significant selling pressure, with a notable decline in its stock price amid consecutive days of losses. Despite a recent weekly gain, the stock has underperformed over the past three months and year-to-date, contrasting sharply with broader market trends.

JFL Life Sciences Ltd, a microcap in the Pharmaceuticals & Biotechnology sector, reached its upper circuit limit today, indicating strong market engagement. The stock showed increased trading activity with a notable rise in delivery volume. It outperformed its sector and is above several key moving averages, highlighting robust performance.

JFL Life Sciences Ltd is experiencing notable buying activity, with a significant increase in its stock price today, outperforming the Sensex. The company has shown strong weekly and monthly gains, although it has faced substantial declines over the past year and three years. Current momentum suggests a potential recovery phase.

JFL Life Sciences Ltd, a microcap in the Pharmaceuticals & Biotechnology sector, experienced significant trading activity today, reaching the upper circuit limit. The stock outperformed its sector with notable trading volume and turnover, indicating a strong market position despite being below longer-term moving averages.